Comprehensive Health Assessment for my Cancer Treatment Plan
CHAMP-F
1 other identifier
interventional
180
1 country
3
Brief Summary
Geriatric assessment (GA) predicts treatment toxicity and overall mortality in older adults with cancer. To improve treatment decision making in older adults with cancer, the American Society of Clinical Oncology (ASCO) and the International Society of Geriatric Oncology recommend implementation of GA for all older adults with cancer. However, in-person GA may not be feasible in several institutions for various reasons, including lack of geriatricians and/or lack of time or resources. These challenges can be minimized through a self-reported online GA that can be completed by patients prior to their medical appointment. In a previous study, the investigators developed a self-reported online GA, known as the Comprehensive Health Assessment for My Cancer treatment Plan (CHAMP) that be used in geriatric oncology to increase accessibility to GA for older adults with cancer. In this study, our aim is to deploy the CHAMP tool to various oncology clinics across 4 institutions and assess feasibility outcomes, as well as the impact of the CHAMP tool on cancer treatment plan and supportive care strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Jul 2023
Typical duration for not_applicable cancer
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedStudy Start
First participant enrolled
July 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedNovember 28, 2025
November 1, 2025
1.8 years
August 2, 2022
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Completeness of the CHAMP tool
Proportion of older adults who consented to the study who completed the CHAMP tool and had a discussion with their oncologist about the CHAMP results.
Within one week from medical appointment
Time to fill out the CHAMP tool
In minutes, recorded via user interaction logs which will include data such as user's actions and interactions with the actual interface such as clicks, point-an-select actions, use of back button, etc.), and whether they completed it alone or needed help.
Within one week from medical appointment
Satisfaction with the CHAMP tool
Measured via open-ended questions and a brief survey.
Older adults - within one week of their medical appointment. Oncologists - within one week of their last study patient.
Secondary Outcomes (2)
Change in proposed treatment plan
Within 48 hours of their appointment with an older adults who has completed the CHAMP tool
Changes in supportive care strategies
Within 48 hours of their appointment with an older adult who completed the CHAMP tool
Study Arms (1)
Older adults completing the CHAMP tool before treatment decision is made
EXPERIMENTALEligible participants who consent to the study will be asked to complete questionnaires about socio-demographic characteristics, literacy, and technology comfort. Subsequently, participants will be asked to complete the CHAMP tool at home or in the clinic before their medical appointment with the oncologist. Next, participants will see their oncologist for their consultation. Approximately one week after the consultation, participants will be asked to complete 3 questionnaires about their experience and satisfaction with the CHAMP tool
Interventions
The CHAMP tool is a self reported online tool that has been developed to increase patients' accessibility to geriatric assessment and improve treatment decision making. The tool includes questions about function, mobility, cognition, nutrition, social support, depression substance use disorders, and miscellaneous items. Based on usability testing in the previous phase of this study, the tool can be completed in approximately 10-15 minutes. The tool generates a summary report with recommendations for patients and clinicians.
Eligibility Criteria
You may qualify if:
- Patients aged 65 years and over referred to surgical oncology, radiation oncology, medical oncology at Princess Margaret Cancer Centre, St. Michael's Hospital, Sunnybrook Health Sciences, or St. Joseph's Health Centre.
- Able to speak and understand English.
- Able to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Unity Health
Toronto, Ontario, Canada
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Shabbir Alibhai, MD
University Health Network, Toronto
- PRINCIPAL INVESTIGATOR
Martine Puts, PhD
University of Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2022
First Posted
August 12, 2022
Study Start
July 24, 2023
Primary Completion
April 30, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
The data of this study may be provided by the principal investigator upon reasonable request and upon approval of the IRB.